The impact of levodopa therapy-induced complications on quality of life in Parkinson’s disease patients in Singapore
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The impact of levodopa therapy-induced complications on quality of life in Parkinson’s disease patients in Singapore ; volume:9 ; number:1 ; day:25 ; month:6 ; year:2019 ; pages:1-6 ; date:12.2019
Scientific reports ; 9, Heft 1 (25.6.2019), 1-6, 12.2019
- Creator
-
Wu, Jonathan
Lim, Ee-Chien
Nadkarni, Nivedita V.
Tan, Eng-King
Kumar, Prakash M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-45110-5
- URN
-
urn:nbn:de:101:1-2019091113354466931253
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wu, Jonathan
- Lim, Ee-Chien
- Nadkarni, Nivedita V.
- Tan, Eng-King
- Kumar, Prakash M.
- SpringerLink (Online service)
Other Objects (12)
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson’s Disease
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson’s Disease
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson’s Disease
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment